May 1, 2010

Low-GDP fluid (Gambrosol trio®) attenuates decline of residual renal function in PD patients: a prospective randomized study

.   .   

This randomized controlled trial of low GDP vs standard peritoneal dialysis solutions concluded that low GDP solutions successfully preserved residual renal function.

See the accompanying editorial by Dr. Joanne Bargman for a critical analysis of the paper.

Related Articles:

Peritoneal Dialysis

Comments are closed.